As BRAF and FGFR1 mutations are typical hallmarks of low-grade gliomas/glioneuronal tumours such as ganglioglioma or pilocytic astrocytoma, the co-occurrence of H3-K27 and these MAPK alterations makes diagnosis and grading difficult [30]. Here, FGFR1 is linked to central nervous system cancer.